Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraven House Capital Regulatory News (CRV)

Share Price Information for Craven House Capital (CRV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.20
Bid: 0.15
Ask: 0.25
Change: 0.00 (0.00%)
Spread: 0.10 (66.667%)
Open: 0.20
High: 0.20
Low: 0.20
Prev. Close: 0.20
CRV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity and Directors' Dealing

27 Feb 2020 11:22

RNS Number : 3668E
Craven House Capital PLC
27 February 2020
 

Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR).

 

Craven House Capital plc

 

("Craven House" or the "Company")

 

Issue of Equity and Directors' Dealing

 

 

The Company announces that Balbir Bindra and Calum Morrison have each been issued 4,904 new ordinary shares ("New Ordinary Shares") as per the terms of their respective appointment letters.

 

As a result of this issue, Balbir Bindra will hold 14,440 Ordinary Shares, representing 0.5% per cent of the Company's issued share capital.

 

As a result of this issue, Calum Morrison will hold 7,356 Ordinary Shares, representing 0.2% per cent of the Company's issued share capital.

 

 

Admission of the New Ordinary Shares to trading on AIM and Total Voting Rights

 

Application will be made for admission of the 9,808 New Ordinary Shares to be issued on the AIM Market of the London Stock Exchange, which is expected to take place at 8.00 a.m. on or around 4 March 2020 ("Admission").

 

The New Ordinary Shares will, when issued, be credited as fully paid and will rank equally in all respects with the existing Ordinary Shares, including the right to receive any dividend or other distribution declared, made or paid after Admission.

 

For the purposes of the Financial Conduct Authority's Disclosure and Transparency Rules ("DTRs"), the issued ordinary share capital of the Company following Admission will consist of 3,063,589 Ordinary Shares of $1.00 with voting rights attached (one vote per Ordinary Share). There are no Ordinary Shares held in treasury. This total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in, the Company under the DTRs.

 

~ Ends ~

 

 

For further information please contact:

 

Craven House Capital Plc

Mark Pajak

www.Cravenhousecapital.com

 

Tel: 0203 286 8130

 

 

SI Capital

Broker

Nick Emerson

www.sicapital.co.uk

Tel: 01483 413500

 

SPARK Advisory Partners Limited

Nominated Adviser

Matt Davis/Mark Brady

www.Sparkadvisorypartners.com

 

 

 

 

Tel: 0203 368 3550

 

 

 

About Craven House Capital:

 

The Company's Investing Policy is to invest in or acquire a portfolio of companies, partnerships, joint ventures, businesses or other assets globally in any geographic jurisdiction. The company will invest in both developed and developing markets providing long term patient capital and is often involved in special situations, restructuring, expansion and turn around investments in crisis and transitioning economies.

 

 

PDMR Notifications

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1. Balbir Bindra

2. Calum Morrison

2.

Reason for the Notification

a)

Position/status

1. Non-Executive Director

2. Non-Executive Director

b)

Initial notification/amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Craven House Capital PLC

b)

LEI

213800NY9RH8O1B72D27

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv)each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of $1.0

Identification code

GB00BD4FQ360

b)

Nature of the Transaction

Issue of ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1. $0

2. $0

1. 4,904

2. 4,904

d)

Aggregated information

Aggregated volume / price

Aggregate volume: 9,808

Aggregated price: $0

e)

Date of the transaction

27 February 2020

f)

Place of the transaction

London Stock Exchange, AIM

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHPPUUPPUPUGGM
Date   Source Headline
22nd Jun 20152:47 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
15th May 20155:53 pmRNSDisposal of investment
8th May 20154:09 pmRNSTR-1: Notification of Major Interest in Shares
6th May 201512:17 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
1st May 201510:45 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
29th Apr 20156:05 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
10th Apr 201511:42 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
18th Mar 20151:00 pmRNSIssue of Equity
27th Feb 20157:00 amRNSInterim Results
4th Feb 201510:30 amRNSUpdate re. Potential Investment
23rd Dec 20144:37 pmRNSAGM Statement
17th Dec 20143:12 pmRNSTR-1: Notification of major interest in shares
12th Dec 201411:42 amRNSStatement re Share Price Movement
12th Dec 20147:00 amRNSChange of Adviser
28th Nov 20147:00 amRNSAnnual Results for year ended 31 May 2014
21st Oct 20144:58 pmRNSUpdate on Pressfit Holdings
10th Oct 20142:09 pmRNSHolding(s) in Company
6th Oct 20144:27 pmRNSHolding(s) in Company
1st Aug 20148:59 amRNSUpdate on Pressfit Holdings
10th Jul 20144:12 pmRNSUpdate on Pressfit Holdings
4th Jun 20149:09 amRNSUpdate on Pressfit Holdings
19th Mar 20147:00 amRNSAcquisition of 49% in Depston Ltd
27th Feb 20148:50 amRNSInterim Results
7th Jan 20149:59 amRNSResult of AGM
9th Dec 20137:00 amRNSIssue of Equity
29th Nov 20137:00 amRNSAnnual Results for year ended 31 May 2013
21st Nov 201311:15 amRNSUpdate on Investment
12th Nov 20135:12 pmRNSHolding(s) in Company
6th Nov 20138:38 amRNSAcquisitions in African Agricultural Businesses
23rd Sep 20133:40 pmRNSUpdate on Farm Lands of Africa
19th Sep 201312:38 pmRNSUpdate on Investment
20th Aug 20139:33 amRNSUpdate on Investment
19th Aug 20139:17 amRNSHoldings in Company
7th Aug 20139:54 amRNSHolding(s) in Company
1st Aug 20134:02 pmRNSHolding(s) in Company
1st Aug 201310:19 amRNSUpdate on Investment
28th May 20133:12 pmRNSLoan Acquisition & Issue of Equity
13th May 201312:37 pmRNSHolding(s) in Company
28th Feb 201310:10 amRNSIssue of Equity
28th Feb 201310:09 amRNSInterim Results
2nd Jan 20139:28 amRNSAcquisition of 50.1% shareholding in Finishtec
21st Dec 201212:03 pmRNSRepayment of Loans
19th Dec 20122:37 pmRNSResult of AGM
26th Nov 20127:00 amRNSNotice of AGM
26th Nov 20127:00 amRNSFinal Results
29th Oct 20121:16 pmRNSHolding(s) in Company
2nd Oct 20127:00 amRNSBoard Appointment in Pressfit Holdings Plc
28th Sep 20127:00 amRNSTotal Voting Rights
24th Sep 20127:00 amRNSAcquisition of 49% shareholding in Ceniako Limited
29th Jun 20128:36 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.